ANI Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Maintains Buy on ANI Pharmaceuticals, Raises Price Target to $87
Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), ANI Pharmaceuticals (ANIP) and Argenx Se (ARGX)
ANI Pharmaceuticals Analyst Ratings
ANI Pharmaceuticals Analyst Ratings
ANI Pharmaceuticals Analyst Ratings
ANI Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Maintains Buy on ANI Pharmaceuticals, Raises Price Target to $83
Analysts Conflicted on These Healthcare Names: Boston Scientific (BSX), ANI Pharmaceuticals (ANIP) and Merck & Company (MRK)
ANI Pharmaceuticals Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: ANI Pharmaceuticals (ANIP), Boston Scientific (BSX)
Truist Securities Adjusts Price Target on ANI Pharmaceuticals to $72 From $70, Maintains Buy Rating
ANI Pharmaceuticals Analyst Ratings
ANI Pharmaceuticals' Strong Performance and Prospects: A Buy Recommendation Amidst Market Disruptions
Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Rani Therapeutics Holdings (RANI) and Novavax (NVAX)
Guggenheim Reiterates Buy on ANI Pharmaceuticals, Maintains $72 Price Target
ANI Pharmaceuticals Analyst Ratings
ANI Pharmaceuticals Analyst Ratings
Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP) and Phathom Pharmaceuticals (PHAT)
ANI Pharmaceuticals Analyst Ratings
No Data